ArticleRheumatology and immunology research2026
Efficacy and safety of Xeligekimab (GR1501) in the treatment of axial Spondyloarthritis: Results from a Phase II clinical trial.
Xiaofeng Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.